Platform for HIV prevention, management, and cure research in Germany
Translational Research Platform of the TTU HIV of the German Center for Infection Research (DZIF)
This study is looking at how to improve HIV prevention and treatment in Germany by bringing together researchers to find better ways to help people living with HIV.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital of Cologne Academic / other |
| Locations | 1 site (Cologne, North Rhine-Westphalia) |
| Trial ID | NCT02149004 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the German Centre for Infection Research's HIV Translational Platform, which aims to address key challenges in HIV management, including prevention, long-term living with HIV, and potential cures. It brings together clinical researchers from various partner sites across Germany to develop new treatment options and enhance existing expertise in HIV research. The study emphasizes the need for tailored research priorities based on the differing economic and epidemiological contexts of developing and developed countries.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who are HIV positive.
Not a fit: Patients who are HIV negative or do not have access to the study locations may not benefit from this study.
Why it matters
Potential benefit: If successful, this platform could lead to improved prevention strategies and treatment options for individuals living with HIV.
How similar studies have performed: Other studies focusing on HIV prevention and management have shown success, indicating that this approach is built on established research foundations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * HIV positive Exclusion Criteria: * None
Where this trial is running
Cologne, North Rhine-Westphalia
- University Hospital of Cologne — Cologne, North Rhine-Westphalia, Germany (Recruiting)
Study contacts
- Principal investigator: Jörg Janne Vehreschild, MD — University Hospital of Cologne
- Study coordinator: Jörg Janne Vehreschild, MD
- Email: janne.vehreschild@ctuc.de
- Phone: +49 221 478 86973
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.